South Korea · Delayed Price · Currency is KRW Lunit Company Description
Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea.
It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer.
The company has a strategic collaboration with AstraZeneca for the development of Lunit SCOPE Genotype Predictor, an AI-powered tool capable of analyzing H&E slide images to predict the likelihood of the tumor harboring NSCLC driver mutations, such as Epidermal Growth Factor Receptor mutations; with Agilent Technologies Inc. to create advanced solutions that meet the demand of novel and complex biomarker assays in drug development; and with Daiichi Sankyo Company, Limited to accelerate biomarker discovery and translational research.
Lunit Inc. was founded in 2013 and is based in Seoul, South Korea.
| Country | South Korea |
| Founded | 2013 |
| Industry | Software - Application |
| Sector | Technology |
| Employees | 307 |
| CEO | Beomseok Brandon Suh |
Contact Details
Address: K-Square Gangnam 2 Seoul South Korea | |
| Phone | 82 2 2138 0827 |
| Website | lunit.io |
Stock Details
| Ticker Symbol | 328130 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7328130000 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Beomseok Brandon Suh | Chief Executive Officer |
| Hyeonseong Park | Chief Financial Officer |